Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium; Department of Obstetrics and Gynaecology, University of Alexandria, Alexandria, 21526, Egypt.
Reproductive Medicine and Surgery, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, United Kingdom.
Best Pract Res Clin Obstet Gynaecol. 2023 Feb;86:102301. doi: 10.1016/j.bpobgyn.2022.102301. Epub 2022 Dec 27.
A high ovarian response to conventional ovarian stimulation (OS) is characterized by an increased number of follicles and/or oocytes compared with a normal response (10-15 oocytes retrieved). According to current definitions, a high response can be diagnosed before oocyte pick-up when >18-20 follicles ≥11-12 mm are observed on the day of ovulation triggering; high response can be diagnosed after oocyte pick-up when >18-20 oocytes have been retrieved. Women with a high response are also at high risk of early ovarian hyper-stimulation syndrome (OHSS)/or late OHSS after fresh embryo transfers. Women at risk of high response can be diagnosed before stimulation based on several indices, including ovarian reserve markers (anti-Müllerian hormone [AMH] and antral follicle count [AFC], with cutoff values indicative of a high response in patients with PCOS of >3.4 ng/mL for AMH and >24 for AFC). Owing to the high proportion of high responders who are at the risk of developing OHSS (up to 30%), this educational article provides a framework for the identification and management of patients who fall into this category. The risk of high response can be greatly reduced through appropriate management, such as individualized choice of the gonadotropin starting dose, dose adjustment based on hormonal and ultrasound monitoring during OS, the choice of down-regulation protocol and ovulation trigger, and the choice between fresh or elective frozen embryo transfer. Appropriate management strategies still need to be defined for women who are predicted to have a high response and those who have an unexpected high response after starting treatment.
卵巢对常规卵巢刺激(OS)的高反应表现为与正常反应(取卵时获得 10-15 个卵母细胞)相比,卵泡和/或卵母细胞数量增加。根据目前的定义,在取卵前,可以在排卵触发日观察到 >18-20 个≥11-12mm 的卵泡时,诊断为高反应;取卵后,可以在获得 >18-20 个卵母细胞时,诊断为高反应。高反应的妇女在新鲜胚胎移植后也有发生早发性卵巢过度刺激综合征(OHSS)/或迟发性 OHSS 的高风险。可以根据一些指标在刺激前诊断出高反应风险的妇女,包括卵巢储备标志物(抗苗勒管激素 [AMH]和窦卵泡计数 [AFC],在 PCOS 患者中,>3.4ng/mL 的 AMH 和 >24 的 AFC 表明存在高反应)。由于有高比例的高反应者有发生 OHSS 的风险(高达 30%),因此本文旨在为识别和管理属于这一范畴的患者提供一个框架。通过适当的管理,可以大大降低高反应的风险,例如个体化选择起始促性腺激素剂量、根据 OS 期间的激素和超声监测进行剂量调整、选择下调方案和排卵触发剂,以及选择新鲜或选择性冷冻胚胎移植。对于预计有高反应的妇女和开始治疗后出现意外高反应的妇女,仍需要定义适当的管理策略。